Concepedia

Yu Chi Yang

YC

Statistics

Publications

27

Citations

3.6K

H-Index

21

Active since

2003

Affiliations

Revolution Medicines (United States)(Current)

BC Cancer Agency

University of Washington

University of British Columbia

Memorial Sloan Kettering Cancer Center

Yu Chi Yang is an author at Revolution Medicines (United States) specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2003–2025

27

Publications

27

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

Eric G. Bluemn, Ilsa M. Coleman, Jared M. Lucas et al. · Cancer Cell · 2017 · 756 citations · Full text

, , +14

Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor

Raymond J. Andersen, Nasrin R. Mawji, Jun Wang et al. · Cancer Cell · 2010 · 508 citations · Full text

, , +17

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown et al. · Journal of Clinical Investigation · 2019 · 468 citations · Full text

, , +17

An androgen receptor N-terminal domain antagonist for treating prostate cancer

Jae‐Kyung Myung, Carmen A. Bañuelos, Javier Fernández et al. · Journal of Clinical Investigation · 2013 · 311 citations · Full text

, , +17

Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS

Christopher J. Schulze, Kyle J. Seamon, Yulei Zhao et al. · Science · 2023 · 232 citations · Full text

, , +17

1–5 of 27